135 related articles for article (PubMed ID: 1710871)
1. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
[TBL] [Abstract][Full Text] [Related]
2. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
[TBL] [Abstract][Full Text] [Related]
3. [Hormonal treatment of carcinoma of the prostate].
Obata K; Kobayashi H; Murase T; Ohisi M
Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy].
Honda M; Takasaki E; Suzuki T; Maeda S; Imai T; Hosoya Y; Chen JA
Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors in stage D2 prostate cancer: results of univariate and multivariate analyses].
Masukagami T; Akimoto S; Akakura K; Shimazaki J; Murakami S
Hinyokika Kiyo; 1996 Apr; 42(4):269-74. PubMed ID: 8693958
[TBL] [Abstract][Full Text] [Related]
7. [A histological evaluation of the therapeutic effects and the clinical findings in prostatic carcinomas].
Koike H; Ishikura K; Fujioka T; Kubo T; Fujie T; Tamura G
Gan No Rinsho; 1990 May; 36(6):715-8. PubMed ID: 2348559
[TBL] [Abstract][Full Text] [Related]
8. [Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy].
Tsukamoto T; Fukui I; Kihara K; Goto S; Kitahara S; Kobayashi T; Kojima S; Oshima H
Hinyokika Kiyo; 1996 May; 42(5):351-6. PubMed ID: 8752537
[TBL] [Abstract][Full Text] [Related]
9. [Present status and questions on early prostatic cancer (stage A, B)].
Oishi K; Arai Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of prostatic cancer--statistical analysis of 184 cases in the latest 21 years].
Yamashita A; Hayashi N; Sugimura Y; Yanagawa M; Arima K; Nakano S; Kimbara H; Tochigi H; Kawamura J
Hinyokika Kiyo; 1995 Jun; 41(6):447-53. PubMed ID: 7645452
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 169 patients with prostate cancer].
Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
[TBL] [Abstract][Full Text] [Related]
12. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
[TBL] [Abstract][Full Text] [Related]
13. [Combination therapy with hormonal, radiation and chemotherapy for stage C prostate cancer].
Iwasawa T; Matsumoto H
Hinyokika Kiyo; 1996 Nov; 42(11):869-74. PubMed ID: 8973937
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on adenocarcinoma of the prostate].
Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
[TBL] [Abstract][Full Text] [Related]
15. Bilateral orchiectomy in the management of stage D-2 prostate cancer.
Guinan P; Firfer R; Targonski P; Rubenstein M
Int Surg; 1993; 78(1):73-5. PubMed ID: 8473090
[TBL] [Abstract][Full Text] [Related]
16. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
Uekado Y
Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of prostatic cancer].
Shimazaki J; Fuse H; Akimoto S; Akakura K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):212-8. PubMed ID: 3341783
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation, apoptosis and prognosis in patients with metastatic prostate cancer.
Furuya Y; Kawauchi Y; Fuse H
Anticancer Res; 2003; 23(1B):577-81. PubMed ID: 12680149
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on recurrent prostatic cancer].
Suzuki K; Nakamura T; Kato N; Suzuki T; Imai K; Yamanaka H
Hinyokika Kiyo; 1991 Jun; 37(6):595-600. PubMed ID: 1892007
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study of prostatic cancer].
Kudo K; Nagata M; Hayashi N; Imamura H; Iwamoto K; Kimura M; Matsubara M; Mimura H; Matsuyama K; Suwa J
Hinyokika Kiyo; 1989 Aug; 35(8):1339-45. PubMed ID: 2816599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]